First China Pharmaceutical Group, Inc.: Exhibit 10.1 - Filed by newsfilecorp.com





PROMISSORY NOTE

	U.S. $500,000.00 	March19, 2012 
	  	(“Effective Date”)



This Promissory Note (“Note”) is being issued by First China
Pharmaceutical Group, Inc., a Nevada corporation (the “Company”), with principal
offices at Number 504, West Ren Min Road, Kunming City, Yunnan Province,
People’s Republic, of China, 650000, to Belmont Group Ltd., a company organized
under the laws of Samoa (“Holder”), with principal offices at Level 5,
Development Bank of Samoa, Beach Road, Apia, Samoa,

     For value received, the Company
promises to pay to Holder, or order, the principal sum of Five Hundred Thousand
U.S. Dollars (U.S. $500,000.00) on or before twelve (12) months from the
Effective Date (the “Due Date”), and to pay simple interest on the unpaid
principal balance from the Effective Date at the annual rate of the lower of
twelve percent (12%) or the highest rate permissible by law. Interest shall
accrue and shall be payable on the Due Date, when all accrued but unpaid
interest and the unpaid principal balance shall be paid in full.

     The Holder, will provide up to
$500,000 in funds to the Company. The Holder requires that the proceeds of this
Note only be used for maintain the Company’s good standing as a public company
with the proceeds being used for the payment of audit fees, legal fees, investor
relations expenses and other costs related to maintaining and developing the
Company in good standing as a public company. The Holder requires that the
$500,000 be utilized by the Company over a 12 month period.

     The Holder, will provide funds to
the Company through draws. The Company can immediately draw up to with up to
$150,000 from the Effective Date. Additional draws to a maximum of $100,000 per
draw, will be provided 30 after the Effective Date, if requested by the Company.
The Company must request draws in writing and the Holder will process and
provide the Company the requested funds within 4 business days from the
Company’s request.

     The Company may at any time,
without penalty, prepay in whole or in part the unpaid balance of this Note.
Each payment shall be credited first to accrued but unpaid interest and the
balance to principal, and interest shall cease to accrue on the amount of
principal so paid. Interest shall be computed on the basis of a year of 365 days
for the actual number of days elapsed. Interest not paid when due shall
thereafter bear like interest as the principal. All payments under this Note
shall be made in lawful currency of the United States of America to the Holder
at _______________.

     Neither this Note nor any rights
hereunder may he assigned, conveyed or transferred, in whole or in part, by the
Company without the Holder’s prior written consent. The rights and obligations
of the Company and the Holder under this Note shall be binding upon and benefit
their respective permitted successors, assigns, heirs, administrators and
transferees.

     This Note shall he governed by
and construed under the internal laws of the State of Nevada as applied to
agreements among Nevada residents entered into and to be performed entirely
within Nevada, without reference to principles of conflict of laws or choice of
laws.

     The Company waives diligence,
presentment, protest, demand and notice of protest, demand, dishonor and
nonpayment of this Note, and expressly agrees that this Note, or any payment
under it, may be extended by the Holder from time to time without in any way
affecting the liability of the Company.

(signature page to follow)

1




     EXECUTED at First China
Pharmaceutical Group, Inc., Kunming City, Yunnan Province, People’s Republic of
China.

	 	First China Pharmaceutical Group, Inc. 
	 	  
	 	By: _________________________
	 	Name: Zhen Jiang Wang 
	 	Title: Chief Executive Officer 
	 	  
	 	  
	 	  
	 	Belmont Group Ltd. 
	 	  
	 	By: _________________________
	 	Name: Jose Pineda 
	 	Title: Manager 


2